Johannes Jan-Willem Cornelis Alffenaar

86PUBLICATIONS
210CO-AUTHORS
Gene and molecular therapyPharmacogenomicsPredictive and prognostic markersDisease surveillanceMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (86)

|Aug 05, 2026
How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis.

|Jul 03, 2026
Recommendations for Assessing Methodological Quality in Systematic Reviews of Population Pharmacokinetic Models: A Systematic Review.

|May 19, 2026
Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy.

|May 13, 2026
Adverse events in bedaquiline- and pretomanid-based regimens for drug-resistant tuberculosis from trial, implementation and pharmacovigilance studies.

|Mar 30, 2026
Does one dose fit all in tuberculosis meningitis treatment?

Jan-Willem C Alffenaar, Sophie L Stocker, Thomas Schön

|Mar 18, 2026
Single Saliva Sample Linezolid Dosing for Multidrug-Resistant Tuberculosis: A Population Pharmacokinetic Modelling of Plasma and Saliva.

Thi A Nguyen, Tri P Nguyen, Anh T Nguyen

Pageof 15

Frequent Collaborators

16 joint publications

Justin Beardsley

13 joint publications

Ana-Alastruey Izquierdo

11 joint publications

Aiken Dao

10 joint publications

Sophie Stocker